In Brief: International Murex Technologies
This article was originally published in The Gray Sheet
Executive Summary
International Murex Technologies: Commences overseas launch of its HIV Antigen Enzyme Immunoassay for the "direct detection and monitoring" of the HIV p24 core antigen. According to a 28-panel study comparing the Murex assay to "four other leading HIV antigen EIAs," the Murex test had the "highest sensitivity" and detected antigen "for a 30 to 60% longer period of time," the company says...